Aptar CSP Technologies is proud to announce that its Dual-Guard Active Material Science Technology has been honored with a Pharma Innovation Award by Pharma Manufacturing magazine. This recognition demonstrates our commitment to innovation and highlights our leadership in pharmaceutical packaging solutions designed to enhance drug stability and patient safety.

The Pharma Innovation Awards, presented annually by Pharma Manufacturing, spotlight cutting-edge solutions that address the industry’s most pressing challenges. Winners are selected by the publication’s editorial team and industry reviewers for their ability to deliver measurable improvements in drug development and manufacturing processes. The awards have become a benchmark for excellence in pharmaceutical manufacturing, highlighting technologies that set new standards for quality and efficiency.

Aptar’s Dual-Guard technology is designed to simultaneously control moisture and oxygen, providing a singular solution to address these critical degradation drivers in sensitive pharmaceutical drugs, such as oral solid dose glucagon-like-peptide-1 (GLP-1), medical devices, implantable mesh devices, transdermal delivery systems and more. By simultaneously protecting against oxidation and humidity,  this technology can help support regulatory compliance and protect performance and integrity of sensitive products without compromising design flexibility.

Receiving the Pharma Innovation Award underscores Aptar CSP Technologies’ role as a trusted partner in pharmaceutical packaging and material science. This recognition validates our ongoing investment in research and development to address critical challenges such as drug stability and patient safety. It also highlights our ability to deliver solutions that anticipate future market needs, reinforcing our position as an innovation leader in the pharmaceutical industry.

For more information about Aptar CSP Technologies’ Dual-Guard Active Material Science Technology, click here to read our latest press release.